(GREAT) BREAKING NEWS: Moderna Submitting its Vaccine for Kids Under 6
Just a few hours ago, Moderna announced it has asked the Food and Drug Administration for Emergency Use Authorization for its COVID vaccine for kids 6 months to under 6 years.
A Moderna executive said all data would be submitted by May 9th. The FDA advisory panel is scheduled to meet in June.
Moderna’s Phase 3 study took place during the Omicron wave, when results should have been worse than at any time in the pandemic. For infection, the vaccine was 51% effective for children 6 months to 2 years and 37% effective for kids 2 through 5. The best news, however was that the antibody results they saw were comparable to what they saw in 12- to 24-year-olds, a group that has very strong protection against severe disease, hospitalization, and death.
This is all great news, especially for parents of children under 6 who’ve been waiting so long for a vaccine for their little ones.
We can’t wait to see the data. And, if it’s as safe and effective as we’re hearing, to start giving the vaccine as soon as it’s approved.